Michelle Hauser, obesity medicine director of the Stanford Lifestyle and Weight Management Center
Natalie Mayslich, Chief Operating Officer of ISSA, captures the urgency clearly, The weight loss landscape is changing dramatically, and trainers and coaches need more than sciencethey need strategies to best help their clients succeed. Beyond the Prescription: Coaching for Sustainable Change GLP-1s are a catalystnot a cure
And if they switched to compounded semaglutide because of the Wegovy shortage, they may be required to switch to the FDA-approved version soon
We cannot stand by and let this continue
Together, they could deliver weight loss that is both substantial and composition-favorable
If this happens, do not attempt to reconstitute a second vial to 'fix' the error